(Press-News.org) Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-powered drug discovery company, has integrated advanced AI chat functionality based on recent advances in large language models into its PandaOmics platform. The new feature, “ChatPandaGPT,” enables researchers to have natural language conversations with the platform and efficiently navigate and analyze large datasets, facilitating the discovery of potential therapeutic targets and biomarkers in a more efficient manner. Insilico Medicine is the first biotech company to implement chat functionality using large language models into its AI drug discovery platform.
PandaOmics is an AI-driven target discovery platform developed by Insilico Medicine that applies deep learning models to identify therapeutic targets associated with a given disease through a combination of omics data analysis put in the context of prior information coming from publications, clinical trials, and grant applications. The algorithm optimizes for the best potential therapeutic targets by scoring results on factors such as novelty, confidence, commercial tractability, druggability, safety, and other key properties that drive target selection decisions.
In November 2022, Insilico Medicine released the addition of a transformer-based knowledge graph to PandaOmics. The neural network of special architecture, the so-called transformer, extracts the relevant information from the list of scientific publications and produces a visually appealing graph that links genes, diseases, chemical compounds, and biological processes. The knowledge graph offers insights into the molecular mechanisms of diseases and the biological activities of genes and compounds in the context of a disease. It also reveals the most promising drug targets and biomarkers.
The new chat functionality, based on large language models, has been integrated with the knowledge graph functionality of PandaOmics and offers a more efficient, accurate, and personalized way to access information on molecular biology, therapeutic target discovery, and pharmaceutical development.
ChatPandaGPT offers additional features over the base on the general-purpose chat models. It draws from a specialized knowledge base, enabling it to provide accurate and detailed information related to molecular biology, therapeutic target discovery, and pharmaceutical development. It uses both natural language processing and machine learning algorithms, allowing it to provide more personalized and relevant responses to users on the platform. ChatPandaGPT is available at all times and can process multiple queries simultaneously without becoming tired or making mistakes.
“Insilico Medicine is excited to integrate this cutting-edge chat functionality into our PandaOmics platform,” said Alex Zhavoronkov, PhD, Founder and CEO of Insilico Medicine. “By enabling researchers to have natural language conversations with the platform, we’re making it easier to navigate complex data and identify potential therapeutic targets and biomarkers.”
PandaOmics is known for its advanced knowledge graph analytics platform, which enables users to discover relationships and insights within complex data structures. By integrating the latest advances in large language models, users can explore data in an even more intuitive and efficient way.
“We’re thrilled to integrate this advanced chat functionality into PandaOmics,” said Frank Pun, PhD, head of the PandaOmics application scientists team. “This integration represents a significant step forward in our efforts to provide researchers with the tools they need to make important discoveries in the field of drug discovery.”
The integration between ChatPandaGPT and PandaOmics is available now, allowing researchers to begin navigating and analyzing large datasets and make important discoveries more efficiently.
About Insilico Medicine:
Insilico Medicine, a clinical-stage end-to-end generative artificial intelligence (AI)-driven drug discovery company, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques to discover novel targets and design novel molecular structures with desired properties. Insilico Medicine is delivering breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system (CNS) diseases, and aging-related diseases.
About PandaOmics:
PandaOmics is a therapeutic target and biomarker discovery platform developed by Insilico Medicine that features advanced knowledge graph analytics and state-of-the-art chat functionality. The platform is designed to help researchers identify potential therapeutic targets and biomarkers in a more efficient and streamlined way. https://insilico.com/pandaomics
END
Insilico Medicine brings AI-powered “ChatPandaGPT” to its target discovery platform
2023-03-13
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Oncotarget | Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells
2023-03-13
“Selective protection of normal cells may transform therapy of cancer.”
BUFFALO, NY- March 13, 2023 – A new review paper was published in Oncotarget's Volume 14 on March 11, 2023, entitled, “Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells.”
Cancer therapy is limited by toxicity in normal cells and drug-resistance in cancer cells. In his latest review, Mikhail V. Blagosklonny, M.D., Ph.D., from Roswell Park Comprehensive Cancer Center discusses the theory that cancer resistance to certain therapies can be exploited ...
Agriculture needs fresh approach to tackle insect resistance to biopesticides, new analysis finds
2023-03-13
Insect pests which attack crops have extraordinary powers to develop resistance to greener pesticides and a new way to manage resistance risks is needed, according to analysis by University of Stirling scientists.
For more than 70 years, agriculture’s response to pesticide resistance has been to seek new pesticides in an endless race to keep up with evolving pests.
Researchers now propose a new way to step off this treadmill as farmers embrace the ongoing green revolution in pest control by switching to biopesticides derived from natural organisms.
The evolution of resistance to biopesticides - a crucial tool in ...
Racial health inequality in prostate cancer associated with facility-level disparities
2023-03-13
Racial minorities in the United States are less likely to receive treatment for prostate cancer and, overall, have worse survival outcomes compared to individuals who are white. Typically, patient-level and physician-level factors have been used to explain the racial and socioeconomic differences in prostate cancer disparities. However, a new study led by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, investigated the role of facilities themselves ...
Scientists develop new concepts about the shape and dynamic nature of molecules
2023-03-13
-With pictures-
Scientists have demonstrated in a new study that carbon-based molecules can be much more dynamic than previously thought.
When a carbon atom forms four bonds to different groups, the molecule can exist in two mirror image forms. These mirror image forms are vital in medicine because they have different biological activities.
Usually, it is impossible to interconvert between these ‘enantiomers’ because to do so would require a bond to be broken, a process that needs too much energy.
The researchers ...
Minke whales are as small as a lunge-feeding baleen whale can be
2023-03-13
A new study of Antarctic minke whales reveals a minimum size limit for whales employing the highly efficient “lunge-feeding” strategy that enabled the blue whale to become the largest animal on Earth.
Lunge feeding whales accelerate toward a patch of prey, engulf a huge volume of water, and then filter out the prey through the baleen plates in their mouths. This strategy is used by the largest group of baleen whales, known as rorquals, which includes blue, fin, humpback, and minke whales.
The ability ...
UK scientists discover a new way to help prevent breast cancer ‘time bomb’
2023-03-13
Scientists have discovered why breast cancer cells that have spread to the lungs may ‘wake up’ following years of sleep - forming incurable secondary tumours.
Their research, funded by Breast Cancer Now, reveals the mechanism that triggers this breast cancer 'time bomb' – and suggests a strategy to defuse it.
Patients with oestrogen receptor positive (ER+) breast cancer – the most common type – have a continued risk of their cancer recurring in another part of their body for many years or even decades after their original ...
The right cocktail of gut enzymes can stop c. diff in its tracks
2023-03-13
Not all probiotics are created equal. In a new study, researchers found that certain enzymes within a class known as bile salt hydrolases (BSHs) can restrict Clostridioides difficile (C. diff.) colonization by both altering existing bile acids and by creating a new class of bile acids within the gut's microbial environment. The work could lead to “designer” probiotics that protect against disease by introducing specific BSHs to the gut after antibiotic treatment.
Selecting the right suite of BSH-producing bacteria is critical, because the study found that interactions between BSHs and bile acids ...
Researchers identify novel genes that may increase risk for schizophrenia
2023-03-13
New York, NY (March 13, 2023) – Researchers have identified two previously unknown genes linked to schizophrenia and newly implicated a third gene as carrying risk for both schizophrenia and autism. Led by the Icahn School of Medicine at Mount Sinai, the multi-center study further demonstrated that the schizophrenia risk conferred by these rare damaging variants is conserved across ethnicities. The study may also point to new therapeutics.
The findings were published in the March 13 online issue of Nature ...
Changing landscapes alter disease-scapes: Study
2023-03-13
A new study has highlighted how and when changes to the environment result in animal-borne disease thresholds being breeched, allowing for a better understanding and increased capacity to predict the risk of transmissions.
For the first time, researchers from Griffith University, Stanford University and the University of California used cumulative pressure mapping and machine learning to better understand how six vector-borne diseases (those transmitted by biting insects) found in different environments responded to the effects of human pressures.
Published in Nature Sustainability, the research found diseases associated with ...
New AI model transforms understanding of metal-organic frameworks
2023-03-13
How does an iPhone predict the next word you’re going to type in your messages? The technology behind this, and also at the core of many AI applications, is called a transformer; a deep-learning algorithm that detects patterns in datasets.
Now, researchers at EPFL and KAIST have created a transformer for Metal-Organic Frameworks (MOFs), a class of porous crystalline materials. By combining organic linkers with metal nodes, chemists can synthesize millions of different materials with potential applications in energy storage and gas separation.
The “MOFtransformer” is designed to be the ChatGPT for researchers that study MOFs. It’s architecture is based ...